197 related articles for article (PubMed ID: 2525236)
21. [99mTc-MAG3 and 131I-OIH in patients with kidney insufficiency and with normal kidneys].
Keske U; Cordes M; Wilfling M; Hunger J; Hosten N; Gahl G
Rofo; 1990 Mar; 152(3):287-92. PubMed ID: 2157251
[TBL] [Abstract][Full Text] [Related]
22. [Clinical assessment of 99mTc-MAG3 scintigraphy for impaired renal function].
Sato M; Hirayama K; Ishikawa N; Takeda T; Wu J; Itai Y; Kobayashi M; Koyama A
Kaku Igaku; 1994 Jan; 31(1):75-84. PubMed ID: 8309113
[TBL] [Abstract][Full Text] [Related]
23. Comparison of technetium-99m MAG3 kit with HPLC-purified technetium-99m MAG3 and OIH in rats.
Coveney JR; Robbins MS
J Nucl Med; 1987 Dec; 28(12):1881-7. PubMed ID: 2960790
[TBL] [Abstract][Full Text] [Related]
24. [A comparison of different methods of calculating clearances using 99mTc-mercaptoacetyltriglycine and 123I- or 131I-ortho-iodohippuric acid].
Keske U; Cordes M; Hosten N; Roll D; Hunger J; Felix R
Nuklearmedizin; 1990 Jun; 29(3):93-100. PubMed ID: 2144045
[TBL] [Abstract][Full Text] [Related]
25. Estimate of relative function and transit time in renographic studies.
González A; Ros D; Pavia J
J Nucl Biol Med (1991); 1994 Sep; 38(3):502-7. PubMed ID: 7865547
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of 99Tcm-bicisate as a renal imaging agent.
Ozker K; Kabasakal L; Liu Y; Hellman RS; Isitman A; Krasnow AZ; Collier BD
Nucl Med Commun; 1997 Aug; 18(8):771-5. PubMed ID: 9293508
[TBL] [Abstract][Full Text] [Related]
27. [Renogram and cystogram using 131I-orthoiodohippurate (131I-OIH) and estimation of the effective renal plasma flow volume (ERPF)].
Maeda M; Yamaguchi M; Hasegawa R; Yoshida H
Kaku Igaku; 1983 May; 20(4):391-8. PubMed ID: 6632366
[No Abstract] [Full Text] [Related]
28. Technetium-99m-MAG3 versus iodine-123-OIH: renal clearance and distribution volume as measured by a constant infusion technique.
Prenen JA; de Klerk JM; van het Schip AD; van Rijk PP
J Nucl Med; 1991 Nov; 32(11):2057-60. PubMed ID: 1834812
[TBL] [Abstract][Full Text] [Related]
29. Phase II study of Tc-99m MAG3 in patients with nephrourologic diseases.
Itoh K; Tsukamoto E; Kakizaki H; Nonomura K; Koyanagi T; Furudate M; Torizuka K
Clin Nucl Med; 1993 May; 18(5):387-93. PubMed ID: 8508572
[TBL] [Abstract][Full Text] [Related]
30. The kidney: imaging with Tc-99m mercaptoacetyltriglycine, a technetium-labeled analog of iodohippurate.
Russell CD; Thorstad BL; Stutzman ME; Yester MV; Fowler D; Dubovsky EV
Radiology; 1989 Aug; 172(2):427-30. PubMed ID: 2526350
[TBL] [Abstract][Full Text] [Related]
31. Filtration fraction and its implications for radionuclide renography using diethylenetriaminepentaacetic acid and mercaptoacetyltriglycine.
Gates GF
Clin Nucl Med; 2004 Apr; 29(4):231-7. PubMed ID: 15096969
[TBL] [Abstract][Full Text] [Related]
32. [Advantages of the new radiopharmaceutic agent, 99mTC-mercaptoacetyltriglycine (99mTc-MAG3), in the diagnosis of kidneydiseases. A comparative study with 131I-OIH, 99mTc-DTPA and 99mTc-DMSA].
Lepej J; Marosová A; Kliment J; Buchanec J; Svitác J; Klisenbauer L
Bratisl Lek Listy; 1992 May; 93(5):258-65. PubMed ID: 1327424
[TBL] [Abstract][Full Text] [Related]
33. Renogram comparison of p-[(18)F]fluorohippurate with o-[(125)I]iodohippurate and [(99m)Tc]MAG3 in normal rats.
Pathuri G; Sahoo K; Awasthi V; Gali H
Nucl Med Commun; 2011 Oct; 32(10):908-12. PubMed ID: 21876402
[TBL] [Abstract][Full Text] [Related]
34. Will 99mTc-MAG3 replace 131I-OIH and 99mTc-DTPA in the follow-up of renal transplants?
Dubovsky EV; Russell CD; Yester MV; Thorstad BL; Ryan JP
Contrib Nephrol; 1990; 79():118-22. PubMed ID: 2146081
[No Abstract] [Full Text] [Related]
35. [Clinical evaluation of 99mTc-MAG3 as a radiotracer to assess the function of transplanted kidney: comparison with 123I-OIH].
Yamamoto K; Takahashi N; Sugimoto K; Yoshida M; Hayashi N; Ishii Y; Nishibuchi S; Muranaka K; Okada K; Miyazaki M
Nihon Igaku Hoshasen Gakkai Zasshi; 1995 May; 55(6):409-13. PubMed ID: 7617467
[TBL] [Abstract][Full Text] [Related]
36. [Functional parameters calculated by 99mTc-MAG3 in transplanted kidney].
Koizumi K; Yamaguchi M; Tooyama K; Uchiyama G; Yamada Y; Ueno A
Kaku Igaku; 1994 Jan; 31(1):17-25. PubMed ID: 8309107
[TBL] [Abstract][Full Text] [Related]
37. Technetium-99m-N,N-ethylenedicysteine--a comparative study of renal scintigraphy with technetium-99m-MAG3 and iodine-131-OIH in patients with obstructive renal disease.
Ozker K; Onsel C; Kabasakal L; Sayman HB; Uslu I; Bozluolçay S; Cansiz T; Kapicioğlu T; Urgancioğlu I
J Nucl Med; 1994 May; 35(5):840-5. PubMed ID: 8176468
[TBL] [Abstract][Full Text] [Related]
38. Effects of altered physiologic states on clearance and biodistribution of technetium-99m MAG3, iodine-131 OIH, and iodine-125 iothalamate.
Taylor A; Eshima D
J Nucl Med; 1988 May; 29(5):669-75. PubMed ID: 2967354
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of Tc-99m mercaptoacetyltriglycine in patients with impaired renal function.
Taylor A; Eshima D; Christian PE; Milton W
Radiology; 1987 Feb; 162(2):365-70. PubMed ID: 2948212
[TBL] [Abstract][Full Text] [Related]
40. Diuresis renography. A simultaneous comparison between 131I-hippuran and 99Tcm-MAG3.
Hvid-Jacobsen K; Thomsen HS; Nielsen SL
Acta Radiol; 1990 Jan; 31(1):83-6. PubMed ID: 2140270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]